←
Alessandro Candreva MD PhD374 posts
Alessandro Candreva MD PhD avatar

Alessandro Candreva MD PhD

@alecandreva

Interv. cardiologist @ University Hospital Zurich | Coordinator of the angiography AGCRC CoreLaboratory | Bio-Eng. PhD in Computational Fluid Dynamics @ PoliTo

◷ Joined May 2010▧ 17 Photos and videos
eosto avatar
⟳ Alessandro Candreva MD PhD retweeted
eosto@eosto1·29 Sep 2024

Please 🙏🏻 repost @OSTOLab1 @ProfPaulEvans @PaneniLab @KralerSimon @BettinaHeideck1 @alecandreva @BarteltLab @MassiRuscica @society_eas @EAPCPresident @AboyansV @BNordestgaard @Metabolcenter

eosto@eosto129 Sep 2024

💥 Tenure-track Assistant Professorship on Pathophysiology of Cardio-metabolic disease @MedUniGraz to conduct cutting-edge translational cardiovascular 🧡 🧬 🔬 💊 research and implement sex and gender-specific novel factors lnkd.in/dxV7Wt8v

Post attachment
NEJM avatar
⟳ Alessandro Candreva MD PhD retweeted
NEJM@NEJM·31 Aug 2024

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio

Post attachment
Davide Capodanno avatar
⟳ Alessandro Candreva MD PhD retweeted
Davide Capodanno@DFCapodanno·31 Aug 2024

In MATTERHORN, among patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery with respect to a composite of death, rehospitalization for heart failure, stroke, reintervention, or implantation of an assist device in the left ventricle at 1 year. Small trial, large noninferiority margin, less events than anticipated in the sample size assumption. #ESCCongress nejm.org/doi/full/10.1056/NE…

Post attachment
Coroventis Research avatar
⟳ Alessandro Candreva MD PhD retweeted
Coroventis Research@coroventis·30 Aug 2024

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B. This represent a paradigm shift in the diagnosis and treatment of these patients.

Post attachment
Alkadhi avatar
⟳ Alessandro Candreva MD PhD retweeted
Alkadhi@Alkadhi_rad·31 Mar 2024

Great study from @MatthEberhard @mergen_v @alecandreva @rengadr @rmanka_ and others from @RadiologieUSZ and @CardioZurich @JACCJournals ⬇️⬇️⬇️⬇️⬇️⬇️

Seeing even more clearly through photon-counting CT (PCCT)? PCCT through in-plane resolution to 0.11mm and through plane resolution to 0.16mm improved coronary stenosis quantification using 3D-QCA as the reference standard. bit.ly/4awzMg5 #YesCCT #JACCIMG @MatthEberhard

Post attachment
Giuseppe Biondi-Zoccai avatar
⟳ Alessandro Candreva MD PhD retweeted
Giuseppe Biondi-Zoccai@gbiondizoccai·23 Mar 2024

Must-read review on the epidemiology and burden of heart failure in Asia in the latest issue of JACC: Asia. Highlights: • In Asia, comprehensive data regarding the epidemiology and burden of HF remain limited. • This review summarizes the occurrence, causes, outcomes, and management of HF in Asia, from both the GBD data and registry studies. • HF remains a serious public health problem in Asia with significant regional variation; thus, strengthening the prevention and standardized management of HF in Asia is urgently needed. jacc.org/doi/10.1016/j.jacas… @JACCJournals

Post attachment
Shruti avatar
⟳ Alessandro Candreva MD PhD retweeted
Shruti@heyshrutimishra·18 Feb 2024

The 7 best TED Talks I've ever seen: 🔖10/10 would Bookmark:

Post attachment